Incidencia de eventos cardiovasculares serios en pacientes con psoriasis moderada-grave tratados con secukinumab

espanolLa psoriasis es una enfermedad cronica. Las formas moderadas-graves se asocian a un incremento del riesgo de enfermedad cardiovascular de 25%. Planteamos un estudio multicentrico, retrospectivo, observacional realizado en practica clinica habitual con 61 pacientes con psoriasis moderada-grave en tratamiento con secukinumab de tres hospitales de Madrid. EnglishPsoriasis is a chronic disease. Severe to moderate forms of psoriasis are associated with an increased risk of 25% of cardiovascular disease. We propose a multicenter, retrospective, observational study performed in routine practice with 61 patients with moderate-severe psoriasis in Secukinumab treatment of three hospitals in Madrid.